Eli Lilly Newswire (Page 2)

Eli Lilly Newswire (Page 2)

Comprehensive Real-Time News Feed for Eli Lilly. (Page 2)

Results 21 - 40 of 1,490 in Eli Lilly

  1. Eli Lilly and Company (LLY) Shares Sold by OLD National Bancorp INRead the original story w/Photo

    Friday Dec 8 | Daily Political

    OLD National Bancorp IN trimmed its stake in Eli Lilly and Company by 1.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 735,489 shares of the company's stock after selling 12,618 shares during the quarter.

    Comment?

  2. Meyer Handelman Co. Reduces Stake in Eli Lilly and CompanyRead the original story w/Photo

    Thursday Dec 7 | IntersportsWire

    Meyer Handelman Co. cut its holdings in shares of Eli Lilly and Company by 18.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission .

    Comment?

  3. First Manhattan Co. Acquires 623 Shares of Eli Lilly and CompanyRead the original story w/Photo

    Thursday Dec 7 | Daily Political

    First Manhattan Co. grew its holdings in shares of Eli Lilly and Company by 0.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission .

    Comment?

  4. Operational Case Studies and Guidance in Overcoming Challenges of...Read the original story

    Thursday Dec 7 | PR.com

    ... An opportunity to benchmark against updates on new technologies, including digital monitoring biomarkers from Eli Lilly; electronic enabled drug delivery devices from MedImmune; and PFS tech transfer of in-line products from Merck Results from ...

    Comment?

  5. How to invest in the next big medical breakthroughRead the original story w/Photo

    Jul 12, 2017 | MoneyWeek

    ... a large biotech such as Biogen, which had 2016 sales of $11.4bn, or even one of the pharmaceutical giants, such as Eli Lilly, whose 2016 revenue came in at $21.2bn. The high risks for Alzheimer's drug developers reflect both the difficulty of ...

    Comment?

  6. Saratoga Research & Investment Management Acquires Shares of 6,962 Eli Lilly and CompanyRead the original story w/Photo

    Wednesday Dec 6 | IntersportsWire

    Saratoga Research & Investment Management bought a new stake in Eli Lilly and Company in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 6,962 shares of the company's stock, valued at approximately $596,000.

    Comment?

  7. Eli Lilly and Company (LLY) SVP Sells $3,152,895.30 in StockRead the original story w/Photo

    Tuesday Dec 5 | Daily Political

    Eli Lilly and Company SVP Susan Mahony sold 36,585 shares of the business's stock in a transaction on Monday, December 4th. The stock was sold at an average price of $86.18, for a total transaction of $3,152,895.30.

    Comment?

  8. Stock Yards Bank & Trust Co. Purchases 1,203 Shares of Eli Lilly and CompanyRead the original story w/Photo

    Tuesday Dec 5 | Daily Political

    Stock Yards Bank & Trust Co. grew its position in shares of Eli Lilly and Company by 3.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission .

    Comment?

  9. ACRES Co-Founder Greg Koski Receives Lifetime Achievement RecognitionRead the original story w/Photo

    Tuesday Dec 5 | PRWeb

    ... Now in its third year, previous awards went to Jean Edwards, Procurement Director for Europe, Australia & Japan at Eli Lilly, in 2016. In 2015, Professor Ken Getz took the inaugural prize for his work as Director and Associate Professor at Tufts ...

    Comment?

  10. Montecito Bank & Trust Cuts Stake in Eli Lilly and CompanyRead the original story w/Photo

    Monday Dec 4 | Daily Political

    Montecito Bank & Trust lessened its holdings in Eli Lilly and Company by 22.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,013 shares of the company's stock after selling 2,050 shares during the period.

    Comment?

  11. FDA Green Lights Eli Lilly's Taltz to Treat Active Psoriatic ArthritisRead the original story w/Photo

    Sunday Dec 3 | BioSpace

    INDIANAPOLIS, Dec. 1, 2017 /PRNewswire/ -- Eli Lilly and Company announced today that the U.S. Food and Drug Administration has approved Taltz injection 80 mg/mL for the treatment of adults with active psoriatic arthritis .1 Taltz was first approved by the FDA in March 2016 for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.1 "PsA is a chronic, progressive and painful form of inflammatory arthritis that impacts approximately 1.6 million Americans living with the disease," said Christi Shaw, president, Lilly Bio-Medicines.

    Comment?

  12. This Morning's Technical Outlook on Drug Makers Stocks --...Read the original story w/Photo

    Monday Dec 4 | PR Newswire

    ... the Drug Manufacturers space have been lined up for assessment, and they are Bristol-Myers Squibb Co. (NYSE: BMY), Eli Lilly and Co. (NYSE: LLY), AbbVie Inc. (NYSE: ABBV), and Johnson & Johnson (NYSE: JNJ). With Wall St. Equities' free research ...

    Comment?

  13. $1.07 Earnings Per Share Expected for Eli Lilly and Company (LLY) This QuarterRead the original story w/Photo

    Sunday Dec 3 | The Breeze

    Analysts predict that Eli Lilly and Company will report earnings of $1.07 per share for the current quarter, according to Zacks . Four analysts have made estimates for Eli Lilly and's earnings, with the lowest EPS estimate coming in at $1.03 and the highest estimate coming in at $1.10.

    Comment?

  14. Rockefeller Financial Services Inc. Reduces Position in Eli Lilly and CompanyRead the original story w/Photo

    Sunday Dec 3 | Daily Political

    Rockefeller Financial Services Inc. decreased its stake in shares of Eli Lilly and Company by 50.2% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,768 shares of the company's stock after selling 4,804 shares during the quarter.

    Comment?

  15. Wealth Enhancement Advisory Services LLC Takes $929,000 Position in Eli Lilly and CompanyRead the original story w/Photo

    Saturday Dec 2 | IntersportsWire

    Wealth Enhancement Advisory Services LLC acquired a new stake in Eli Lilly and Company in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 10,670 shares of the company's stock, valued at approximately $929,000.

    Comment?

  16. Aldebaran Financial Inc. Has $490,000 Holdings in Eli Lilly and CompanyRead the original story w/Photo

    Friday Dec 1 | Daily Political

    Aldebaran Financial Inc. raised its holdings in Eli Lilly and Company by 16.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission . The firm owned 5,950 shares of the company's stock after buying an additional 850 shares during the quarter.

    Comment?

  17. Ardsley Advisory Partners Has $206,000 Holdings in Eli Lilly and CompanyRead the original story w/Photo

    Friday Dec 1 | IntersportsWire

    Ardsley Advisory Partners lowered its stake in shares of Eli Lilly and Company by 66.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,500 shares of the company's stock after selling 5,000 shares during the period.

    Comment?

  18. Eli Lilly and Company (LLY) Shares Sold by Kimelman & Baird LLCRead the original story w/Photo

    Thursday Nov 30 | Daily Political

    Kimelman & Baird LLC reduced its stake in shares of Eli Lilly and Company by 17.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 132,007 shares of the company's stock after selling 27,576 shares during the quarter.

    Comment?

  19. Oak Associates Ltd. OH Holds Holdings in Eli Lilly and CompanyRead the original story w/Photo

    Thursday Nov 30 | IntersportsWire

    Oak Associates Ltd. OH maintained its stake in Eli Lilly and Company during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,500 shares of the company's stock at the end of the 2nd quarter.

    Comment?

  20. Eli Lilly and Company (LLY) Expected to Post Quarterly Sales of $5.93 BillionRead the original story w/Photo

    Thursday Nov 30 | AmericanBankingNews.com

    Analysts expect Eli Lilly and Company to report sales of $5.93 billion for the current quarter, Zacks reports. Four analysts have made estimates for Eli Lilly and's earnings, with the highest sales estimate coming in at $6.04 billion and the lowest estimate coming in at $5.82 billion.

    Comment?